Delhi HC clears Zydus to sell biosimilar of BMS cancer drug Nivolumab
[ad_1] The Delhi High Court on Monday cleared the way for Zydus Lifesciences to manufacture and sell a biosimilar version of Nivolumab, a blockbuster cancer drug patented by US pharmaceutical major Bristol Myers Squibb (BMS), delivering a significant boost to the Indian drugmaker just months before the patent expires. A division bench set aside an…